REGN:NASDAQ
Regeneron Pharmaceuticals Inc
$788.04
arrow_downward
-1.00%(-7.98) 1D
$788.04
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 25, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN...
Open
$803.87
High
$803.87
Low
$784.13
Mkt. cap
81.13B
Avg. vol.
682.01K
Volume
592.14K
Dividend
0.48%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
19.48
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
Open
$803.87
High
$803.87
Low
$784.13
Mkt. cap
81.13B
Avg. vol.
682.01K
Volume
592.14K
Dividend
0.48%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
19.48
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.20
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
News Corp
·
5 hours ago
Regeneron Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
AD HOC NEWS
·
8 hours ago
Regeneron stock last at USD 792.19, down 1.20 percent in New York trading
Zacks
·
11 hours ago
Sanofi's New Drugs Poised to Drive Growth Beyond Dupixent
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com